Results
95
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
95 companies
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩25,700.00
7D
0.2%
1Y
2.2%
Granules India
Market Cap: ₹125.7b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹518.05
7D
10.3%
1Y
-26.3%
Green Thumb Industries
Market Cap: CA$2.8b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$11.38
7D
-7.0%
1Y
-12.7%
Selvita
Market Cap: zł569.0m
Operates as a contract research organization worldwide.
SLV
zł31.00
7D
-0.6%
1Y
-50.9%
Medical Developments International
Market Cap: AU$65.3m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.58
7D
0%
1Y
30.3%
Medy-Tox
Market Cap: ₩840.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩119,800.00
7D
0.3%
1Y
-31.6%
ABL Bio
Market Cap: ₩5.3t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩95,500.00
7D
0.8%
1Y
246.6%
Solara Active Pharma Sciences
Market Cap: ₹32.5b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹675.75
7D
11.1%
1Y
-9.8%
Diaceutics
Market Cap: UK£118.4m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.40
7D
1.8%
1Y
9.4%
Knight Therapeutics
Market Cap: CA$642.8m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$6.47
7D
-0.3%
1Y
15.1%
Aspen Pharmacare Holdings
Market Cap: R45.1b
Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.
APN
R101.57
7D
-5.9%
1Y
-49.3%
PeptiDream
Market Cap: JP¥199.2b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,481.00
7D
-2.8%
1Y
-41.9%
Nanjing Vazyme Biotech
Market Cap: CN¥9.2b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥22.79
7D
-6.8%
1Y
16.8%
Aroa Biosurgery
Market Cap: AU$224.3m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.65
7D
0%
1Y
23.8%
Laurus Labs
Market Cap: ₹472.2b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹874.70
7D
0.7%
1Y
83.9%
Indoco Remedies
Market Cap: ₹26.0b
Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹281.75
7D
1.6%
1Y
-24.8%
Swedencare
Market Cap: SEK 6.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 39.15
7D
-1.1%
1Y
-9.7%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł210.1m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł38.00
7D
-7.5%
1Y
-48.6%
BrightGene Bio-Medical Technology
Market Cap: CN¥38.1b
A pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.
688166
CN¥88.60
7D
-9.6%
1Y
243.9%
Organogenesis Holdings
Market Cap: US$621.6m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$4.96
7D
2.5%
1Y
83.7%
Navamedic
Market Cap: NOK 381.5m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.60
7D
-1.8%
1Y
-23.7%
Nxera Pharma
Market Cap: JP¥87.2b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥970.00
7D
7.3%
1Y
-27.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥53.2b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥111.89
7D
-1.3%
1Y
137.6%